Financial News
Headline News about Catalyst Pharm Inc
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/january/mmc/mmc-stats-0123.jpg?sfvrsn=5706ac06_0)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1523.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/23/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/23/image24.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Analyst Expectations for Catalyst Pharmaceuticals's Future
January 19, 2023
Via Benzinga
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/23/cprx_logo_light__82963f5650c4da573ca4d8c38d44df2f.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/23/image21.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/09/Stock-CatalystPharmaceuticals-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/23/vaccine-4892048_1.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/images/story/2022/12/20/logo_light__82963f5650c4da573ca4d8c38d44df2f.png?width=1200&height=800&fit=crop)
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
December 20, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/712866/researchers-pipette-samples-at-lab-bench.jpg)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-moderna-04-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/image-best_buy_0.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-BoardArrowUp-04-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2022/09/Stock-CatalystPharmaceuticals-01-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/705431/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-Biotech-11-Adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/16/image-fedex_0.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.